FDA Finds Flaws at Vaccine Factory, Accepts Moderna's Assurances [Business News Network (BNN) (Canada)]
Catalent, Inc. (CTLT)
Last catalent, inc. earnings: 2/3 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
investor.catalent.com
Company Research
Source: Business News Network
Some pharmaceuticals produced at the plant had visible particles that the company failed to thoroughly look into, investigators with the US Food and Drug Administration said in a report released Tuesday. Catalent received 179 complaints about particles over two years, the agency said. “A recent FDA inspection at our Bloomington facility resulted in observations that Catalent is already addressing, as it seeks to continuously improve its operations,” the company said in an email. “Production at the facility has continued without interruption.” Catalent's protocols weren't adequate to prevent contamination, and errors weren't properly investigated, according to the report from FDA inspectors who visited the facility in Bloomington, Indiana, in August and September. Moderna, in the thick of the fall booster push, asked the FDA to review certain batches of its Covid-19 shot made at the plant and release them to meet demand. Pharmacies and other vaccine providers have reported tight
Show less
Read more
Impact Snapshot
Event Time:
CTLT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CTLT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CTLT alerts
High impacting Catalent, Inc. news events
Weekly update
A roundup of the hottest topics
CTLT
News
- Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Catalent, Inc. (CTLT) InvestigationAccesswire
- Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Catalent, Inc. (CTLT) InvestigationAccesswire
- SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTLT, HRT, CHRDGlobeNewswire
- Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Catalent, Inc. (CTLT) InvestigationAccesswire
- Catalent, Inc. (NYSE: CTLT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
CTLT
Earnings
- 2/9/24 - Miss
CTLT
Sec Filings
- 4/22/24 - Form DEFA14A
- 4/15/24 - Form DEFM14A
- 4/9/24 - Form S-8
- CTLT's page on the SEC website